The diffusion of generics after patent expiry in Germany-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The diffusion of generics after patent expiry in Germany

Published:2015-11-16 Issue:8 Volume:17 Page:1027-1040
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

Fischer Katharina Elisabeth,Stargardt Tom

Funder

Federal Ministry of Education and Research in Germany

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-015-0744-3.pdf

Reference68 articles.

1. Danzon, P.M., Furukawa, M.F.: Cross-national evidence on generic pharmaceuticals: pharmacy vs. physician-driven markets. NBER working paper 17226. http://www.nber.org/papers/w17226 (2011)

2. Dunne, S., Shannon, B., Dunne, C., Cullen, W.: A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol. Toxicol. 5(14), 1 (2013)

3. Rischatsch, M., Trottmann, M., Zweifel, P.: Generic substitution, financial interests, and imperfect agency. Int. J. Health Care Finance Econ. 13(2), 115–138 (2013)

4. Duflos, G., Lichtenberg, F.R.: Does competition stimulate drug utilization? The impact of changes in market structure on US drug prices, marketing and utilization. Int. Rev. Law Econ. 32(1), 95–109 (2012)

5. Kanavos, P., Costa-Font, J., Seeley, E.: Competition in off-patent drug markets: issues, regulation and evidence. Econ. Policy 23(55), 499–544 (2008)

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A five-year analysis of market share and sales growth for original drugs after patent expiration in Korea;2024-09-10

2. Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation;PLOS ONE;2024-05-02

3. Market diffusion of biosimilars in off-patent biologic drug markets across Europe;Health Policy;2023-06

4. Multi-Agent Collaborative R&D Strategies of General-Purpose Technologies: Commonality and Synergy Perspective;Tehnicki vjesnik - Technical Gazette;2023-04-15

5. The same old medicine but cheaper: The impact of patent expiry on physicians’ prescribing behaviour;Journal of Economic Behavior & Organization;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3